BK virus in saliva after kidney transplant
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This study checks whether BK virus, which can cause problems after a kidney transplant, is found in saliva. It may help find a simpler way to monitor patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have had a kidney transplant
- You are 18 years or older
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study will collect blood samples from people having a kidney biopsy or a kidney transplant to look for biomarkers (biological signs) that can give doctors more information about kidney health. Participating may help doctors better understand and treat kidney disease in the future.
This study looks at how CMV (a common virus) affects the immune system in people who get a kidney transplant or have CMV after transplant. It may help doctors understand and manage CMV better.
This study looks at the type and genetic makeup of BK virus in kidney transplant patients and their donors. It aims to find patients at higher risk for a kidney infection caused by the virus, which could help improve monitoring and treatment.
This study looks at how the body’s immune system responds when a kidney transplant shows signs of rejection, using a planned kidney biopsy. It may help doctors better understand what drives rejection and how to improve care in the future.
This study looks at certain immune cells (B cells) in the blood and kidney to better understand antibody-mediated rejection in kidney transplant patients. It might help doctors find new ways to diagnose or treat this type of rejection.
This study looks for small pieces of kidney DNA in the blood of kidney transplant patients. It aims to improve monitoring of transplant health.
Hear when a new Kidney Transplantation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.